Neuropathic pain (NeP) results from injury to, or disease of, the peripheral or central components of the neural systems involved in pain. In contrast to inflammatory pain, NeP can persist after healing from the initial injury has resolved. Antipyretic agents, such as non-steroidal anti-inflammatory drugs, steroids, and acetaminophen are ineffective, while specific agents such as gabapentinoids, antidepressants, antiepileptics, and opioids are effective in treating NeP. In this review, we address the definition of NeP, pharmacotherapy for NeP in Japan, pain classification, setting goals for successful NeP medication, and the Japanese algorithm for the pharmacotherapy of NeP with specific prescription guidance. (J Nippon Med Sch 2017; 84: 258 267) 
Introduction
Pharmacotherapy for alleviating neuropathic pain (NeP), which manifests as numbness and pain, is the most fundamental and important noninvasive support tool for the home-based care of patients and their families. When administered properly, pharmacotherapy alleviates suffering from NeP, which in turn facilitates rehabilitation for preserving physical function. Pain alleviation also gives patients time to make careful decisions about surgery.
Because NeP is a common physical condition, especially in an aging society such as Japan, treating NeP is not only challenging but also very important for both specialists and non-specialists. The development of a medical care algorithm for the management of NeP 1 has been led by the Japan Society of Pain Clinicians (JSPC).
This paper presents an algorithm for the pharmacotherapy of NeP, discusses important treatment points, and focuses on treatments by Japanese non-specialists.
The most important clinical considerations in the pharmacotherapy for NeP are as follows:
Screening and evaluation of the pain are essential prior to starting pharmacotherapy. Physicians must screen sensory function, reflexes, and motor function, as well as physical function. Annual screening and X-ray, CT, and MRI findings are needed to recognize neuropathy.
NeP therapy is likely to be effective if the site of pain has a sensory abnormality, such as numbness, or shooting, lancinating, stabbing, or burning pain.
Pharmacotherapy should be prescribed to avoid early central nervous adverse reactions such as sleepiness, dizziness and falls.
The dose should be started at a very low level and titrated to the optimal level while adverse reactions are carefully monitored.
Definition of NeP
The International Association for the Study of Pain (IASP) defines neuropathic pain as pain arising as a direct consequence of a lesion or disease affecting the somatosensory system. 2 al. 2 and Haanpää et al. 3 .
A careful history and examination are essential for the diagnosis of NeP. In addition, there should also be an awareness of the need to consider the pain mechanism as follows:
1) Questions about altered sensation and motor weakness.
2) To evaluate altered or absent sensations, it is important to assess the response to a pin-prick, vibration, hot, cold, or simple touch, in addition to mapping the sen- 3) Additional examinations (laboratory tests, nerveconduction examinations, X-rays, CT, MRI, and tissuebiopsy) might also be performed in order to help identify NeP.
Setting the Goals for Successful Pain Management
As stated in the beginning, analgesic therapy, which alleviates physical suffering in a home-based setting, is the most fundamental form of noninvasive relief that can be managed by the patient. However, patients prescribed analgesics must be advised that pharmacotherapy for NeP is not curative, and that analgesics should be used to ultimately preserve or improve physical function.
Patients also need to be informed that analgesics are intended to alleviate the symptoms of pain and that the overall focus of treatment must be on resolving the underlying causes and improving physical function. When treating a patient with noncancer NeP, physicians need to set goals to improve physical function, no matter how small at every visit. Examples include being able to sleep through the night, getting strong enough to be able to transfer to a wheelchair, being able to undertake certain tasks, walk around the neighborhood, or go shopping, etc. Being able to carry out certain tasks is a suitable goal, as many of these are easy to perform. Repeated small successes encourages patients by giving them a better idea of the importance of pharmacotherapy. However, if the pharmacotherapy proves to be ineffective, the patient's prescription should be tapered or discontinued.
The following 4 A's have been proposed for the use in assessing the efficacy of the pharmacotherapy: Checking for aberrant behavior is an important factor in patients receiving opioid therapy.
Pain Classification
Pain has been classified as follows:
A. Physical pain appears as (1) nociceptive pain, (2) neuropathic pain, and (3) mixed pain ( The terms stinging pain , electric-like pain , burning pain , and numbness are typical ways used to express neuropathic pain. Table 2 shows the Japanese terms used during interviews to screen for the presence of neuropathic pain 6 .
NeP does not respond to antipyretic analgesics (acetaminophen, NSAIDs, and COX-2 inhibitors). Pharmacotherapies that do work include neuroactive pregabalin, gabapentin, antiepileptics, tricyclic antidepressants (TCAs), and serotonin/noradrenaline reuptake inhibitors, among others. However, changes in the weather can often also cause flare-ups of NeP.
Although nociceptor injury heals relatively quickly, resulting in quick resolution of nociceptive pain, nerve damage is very slow to heal and may not heal at all in elderly subjects. NeP persists for months, years, or even until death. Therefore, patients need to be encouraged to relax during the long healing process, which could take years.
Pharmacotherapy for NeP in Japan
Analgesic therapy must not interfere with curative treatments. Basic requirements for the use of analgesics for NeP are:
Take into account the balance between efficacy and adverse reactions.
Free from organ damage with long-term use.
Less drug-drug interactions. The Japanese NeP Screening Questionnaire contains 7 questions with 5 levels. In a study of 238 Japanese patients with chronic pain, patients with NeP were identified with a sensitivity and specificity of 70% and 76%, respectively, with a cutoff value of 9 points on the total score (0 28 points: evaluated with 5 levels of 0 4) 6 .
world. These recommendations encourage physicians to strike a balance between the efficacy, or the number needed to treat (NNT), and the adverse reactions, or the number needed to harm (NNH).
1) Pharmacotherapeutic algorithm for nociceptive pain
Acetaminophen, which has an excellent safety and tolerability profile, is a first-line treatment when an antiinflammatory effect is not required. An NSAID, or selective COX-2 inhibitor, should be used in patients with extensive inflammation but no cardiovascular or renal risk factors. However, these drugs should only be used after taking into consideration possible cardiovascular (hypertension, and ischemic heart disease), gastrointestinal, and renal disorders. Tramadol or another weak opioid should be considered for moderate or greater pain, while a strong opioid should be considered for more severe pain.
2) Pharmacotherapeutic algorithm for NeP In addition, while pregabalin has been approved for central and peripheral NeP (all kinds of NeP), and gabapentin has been approved for partial seizures, the use of gabapentin for NeP is still off-label in Japan.
b) Duloxetine
Duloxetine in one of the SNRIs that are viewed as being safer to use compared with TCAs. The advantage of duloxetine is that it also can be used to effectively treat depression, diabetic NeP, and other NeP conditions. Although nausea is the most common side effect, its occurrence appears to be reduced when patients are started at is necessary to prescribe a drug for NeP, including an opioid, these patients need to be kept from driving. In addition, physicians must periodically check for package insert revisions.
2) Awareness of the adverse reaction profiles of analgesic drugs
Although elderly patients tolerate acetaminophen and low-dose pregabalin well, higher doses of pregabalin can cause dizziness and sleepiness, TCAs may cause constipation, urinary disorders, and increased intraocular pressure, and opioids may cause constipation, nausea, and other reactions, which overall can result in a lower tolerance. Table 5 lists the advantages and disadvantages that need to be considered when selecting a drug for NeP.
The considerations required for opioids are discussed later.
3) Specific prescription guidance (pharmacotherapy for NeP)
Start treatment at the lowest dose.
Tell the patient to take the drug after supper if there is concern that they might wake to go to the bathroom at night, which is often the cause of a fall while on the medication.
Start elderly patients at one 25 mg capsule of pregabalin at bedtime once daily.
Note: The 150 mg/day starting dose listed in the package insert may be excessive for some elderly Japanese patients. This dosage can cause light-headedness and falls.
Tell the patient in advance that the dose will be gradually increased over several days or weeks. Antidepressants have similar profiles and prescribing precautions (e.g., dizziness, constipation, intraocular pressure effects, and serotonin syndrome) 7 . Table 5 presents the advantages and disadvantages of the same-class analgesics.
When inappropriate, pregabalin may be replaced with gabapentin or clonazepam, although it is also possible to use them off-label for NeP in Japan.
Low-dose clonazepam causes few serious adverse drug reactions and is well tolerated, but it has a long half-life of 1 to 2 days. Thus, initial dose regimens should be prescribed with caution, for example, one dose every few days.
The TCA nortriptyline (starting at 10 mg/day, offlabel use) is better tolerated than the on-label drug amitriptyline.
Duloxetine is effective but expensive. For example, acetaminophen and tramadol can be independently administered, instead of as a two-drug combination product such as TRAMCET combination tablets.
Administration as separate agents facilitates any dose adjustments required during the course of the treatment.
Considerations for Starting Opioid Treatment
The opioid products shown in Figure 3 are available for moderate to severe non-cancer pain, in addition to their use in cancer pain. Characteristics common to all opioids are listed below. Opioids provide a highly reproducible pharmacological action but, when used chronically, can lead to improper or illicit use. This is why they should be considered only if the patient fails to respond to non-opioid treatment and why they are positioned after the second-line treatments 3, 8 .
Advantages and disadvantages of long-term opioid therapy 9 11 Advantages:
(1) Consistent, reproducible efficacy.
(2) Long-term use does not normally cause organ damage (but can affect the immune system and reproductive function if used for years).
Disadvantages:
(1) Adverse reactions include constipation, nausea, sleepiness, and sedation.
(2) Physical and psychiatric dependence may occur as the patient develops tolerance.
Opioids other than tramadol, and in particular the strong opioids, pose concerns for improper and illicit use. Carefully consider the following criteria before prescribing them.
Criteria for prescribing opioids for non-cancer NeP:
1. The organic cause of the persisting pain is clear, and the pain has minimal psychogenic involvement.
2. All non-opioid pain relief options are ineffective.
3. The patient is aware of the goals and adverse effects of opioid treatment.
4. The patient is able to comply with the treatment regimen and maintain good compliance with the medication.
5. The patient has no history of dependence (e.g., drugs, alcohol, smoking, compulsive substance abuse, or abnormal consumer behavior).
6. The patient is eager to return to work or school.
Generally, patients requiring an equivalent of 120 mg/ day or greater of morphine should be referred to a higher order pain institution or pain specialist 1 . It must be remembered that weak opioids, at high doses, can also cause problems similar to those observed for the strong opioids (dependence, improper use, adverse drug reactions, and immune/reproductive effects). Figure 3 presents the dose equivalents of the opioids available in Japan for treating NeP (equipotent opioid analgesic doses with morphine).
Physicians who prescribe opioids must remain vigilant in order to ensure that their patients benefit from the opioid prescription and that there is an absence of social (abuse, illicit use, or driving) and physical (dependence, abuse, poor concentration, or sedation) problems 9 11 . As previously noted, physicians always need to keep in mind the four A's (analgesia, activity, adverse effects, aberrant behavior) when treating patients. Furthermore, when opioid treatments result in little benefit, physicians should consider referring the patient to a medical institution with a pain specialist.
Conclusion
NeP is commonly encountered in the primary care set- 
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